Brigit Riley's Insider Trades & SAST Disclosures
Brigit Riley's most recent trade in Adverum Biotechnologies Inc was a trade of 7,299 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on March 15, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brigit Riley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc | Brigit Riley | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 15 Mar 2023 | 7,299 | 117,435 (0%) | 0% | 0.8 | 5,705 | Common Stock |
| Adverum Biotechnologies Inc | Brigit Riley | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Brigit Riley | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 19 Sep 2022 | 7,266 | 118,734 (0%) | 0% | 1.1 | 7,772 | Common Stock |
| Adverum Biotechnologies Inc | Brigit Riley | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 95,931 | 95,931 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Brigit Riley | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 68,482 | 68,482 | - | - | Performance Based Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Brigit Riley | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges